[EN] TRIAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉ DE TRIAZOLOPYRIDINE, COMPOSITIONS ET PROCÉDÉS D'UTILISATION ASSOCIÉS
申请人:HOFFMANN LA ROCHE
公开号:WO2015032286A1
公开(公告)日:2015-03-12
Compounds of Formula 0, Formula I and Formula II and methods of use as Janus kinase inhibitors are described herein.
TRIAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
申请人:F. Hoffmann-La Roche AG
公开号:EP3041841B1
公开(公告)日:2019-06-05
TRIAZOLO PYRIDINES AS MODULATORS OF GAMMA-SECRETASE
申请人:Boehringer Ingelheim International GmbH
公开号:EP3672971B1
公开(公告)日:2021-07-14
TRIAZOLOPYRIDINE COMPOUNDS AND METHODS OF USE THEREOF
申请人:Genentech, Inc.
公开号:US20180086757A1
公开(公告)日:2018-03-29
Provided are triazolopyridine compounds that are inhibitors of JAK kinase, such as JAK1, compositions containing these compounds and methods for treating diseases mediated by a JAK kinase. In particular, provided are compounds of formula (I), stereoisomers, tautomers, solvates, prodrugs or pharmaceutically acceptable salts thereof, where R
1a
, R
1b
, R
1c
, R
2
, R
3
, R
4
and R
5
are defined herein, pharmaceutical compositions comprising the compound and a pharmaceutically acceptable carrier, adjuvant or vehicle, methods of using the compound or composition in therapy, for example, for treating a disease or condition mediated by a JAK kinase in a patient.